These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 1282105)
1. CR 2039, a new bis-(1H-tetrazol-5-yl)phenylbenzamide derivative with potential for the topical treatment of asthma. Revel L; Colombo S; Ferrari F; Folco G; Rovati LC; Makovec F Eur J Pharmacol; 1992 Dec; 229(1):45-53. PubMed ID: 1282105 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of HSR-6071, a new anti-allergic agent, on experimental asthma in rats and guinea-pigs. Makino E; Ohashi T; Takahashi H; Kato H; Ito Y; Nagai H; Koda A; Azuma H J Pharm Pharmacol; 1990 Apr; 42(4):236-41. PubMed ID: 1974289 [TBL] [Abstract][Full Text] [Related]
3. Antiallergic and cytoprotective activity of new N-phenylbenzamido acid derivatives. Makovec F; Peris W; Revel L; Giovanetti R; Redaelli D; Rovati LC J Med Chem; 1992 Oct; 35(20):3633-40. PubMed ID: 1433173 [TBL] [Abstract][Full Text] [Related]
4. Bronchoprotective effect of an intrabronchial administration of cilostazol powder and a nebulized PDE1 and PDE4 inhibitor KF19514 in guinea pigs. Fujimura M; Tachibana H; Myou S; Kita T; Matsuda T Int Arch Allergy Immunol; 1998 Jul; 116(3):220-7. PubMed ID: 9693270 [TBL] [Abstract][Full Text] [Related]
5. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent. Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995 [TBL] [Abstract][Full Text] [Related]
7. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate. Nabe T; Yamamura H; Kohno S; Ohata K Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084 [TBL] [Abstract][Full Text] [Related]
8. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models. Kobayashi K; Hiroi J; Kishi S; Sawase K; Hirayama Y; Chihara S; Imai T; Shigi Y; Shimomura K; Kohsaka M Jpn J Pharmacol; 1993 Sep; 63(1):73-81. PubMed ID: 7505860 [TBL] [Abstract][Full Text] [Related]
9. Effect of 8-hexyloxy-3-(1H-tetrazol-5-yl)-2H-chromen-2-one [KP-136] on experimental asthma: a comparison with disodium cromoglycate. Kuriyama K; Hiyama Y; Ito K J Pharmacobiodyn; 1989 Mar; 12(3):175-81. PubMed ID: 2474641 [TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Raeburn D; Underwood SL; Lewis SA; Woodman VR; Battram CH; Tomkinson A; Sharma S; Jordan R; Souness JE; Webber SE Br J Pharmacol; 1994 Dec; 113(4):1423-31. PubMed ID: 7889300 [TBL] [Abstract][Full Text] [Related]
11. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent. Yanni JM; Stephens DJ; Miller ST; Weimer LK; Graff G; Parnell D; Lang LS; Spellman JM; Brady MT; Gamache DA J Ocul Pharmacol Ther; 1996; 12(4):389-400. PubMed ID: 8951675 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of aerosol administration of a sulfidopeptide leukotriene antagonist on bronchoconstriction induced by antigen inhalation in guinea pigs. Bando T; Fujimura M; Shintani H; Saito M; Kurashima K; Nishi K; Matsuda T Arzneimittelforschung; 1994 Jun; 44(6):754-7. PubMed ID: 8053975 [TBL] [Abstract][Full Text] [Related]
13. Antiallergic properties of an orally effective agent, [[3-(1H-tetrazol-5-yl)-phenyl] amino] oxoacetic acid n-butyl ester. Agata M; Goto H; Tsuriya Y; Tachibana K; Kuroda T Jpn J Pharmacol; 1982 Aug; 32(4):689-97. PubMed ID: 6182323 [TBL] [Abstract][Full Text] [Related]
14. [Experimental study on the action mechanism of a new bronchodilator agent, BB-1502]. Kamei H; Obi Y; Kawano K; Hirano M; Murata S; Imanishi H Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):335-42. PubMed ID: 6200410 [TBL] [Abstract][Full Text] [Related]
15. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models. Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367 [TBL] [Abstract][Full Text] [Related]
16. Potent inhibitory activity of HSR-6071, a new antiallergic agent, on passive cutaneous anaphylaxis (PCA). Makino E; Ohashi T; Takahashi H; Kato H; Ito Y; Nagai H; Koda A; Azuma H Jpn J Pharmacol; 1990 Jan; 52(1):87-94. PubMed ID: 1689783 [TBL] [Abstract][Full Text] [Related]
17. In vivo anti-allergic and bronchopulmonary pharmacology of REV 3164 in rats and guinea-pigs. Leibowitz M; Gordon RJ; Wolf PS; Sonnino-Goldman P Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):135-54. PubMed ID: 6497506 [TBL] [Abstract][Full Text] [Related]
18. CI-922--a novel, potent antiallergic compound--II. Activity in animal models of allergy. Adolphson RL; Finkel MP; Robichaud LJ Int J Immunopharmacol; 1987; 9(1):51-60. PubMed ID: 2438239 [TBL] [Abstract][Full Text] [Related]
19. Effect of butyl 3-(1H-tetrazol-5-Yl) oxanilate (MTB) on immunological or non-immunological histamine and SRS(-A) release from guinea-pig, monkey and human lung tissue. Hashimoto T; Kohno SW; Ohata K; Yanagihara Y; Shida T Jpn J Pharmacol; 1987 Aug; 44(4):447-53. PubMed ID: 2446036 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of immediate hypersensitivity reactions in laboratory animals by a phenanthroline salt (ICI 74,917). Evans DP; Thomson DS Br J Pharmacol; 1975 Mar; 53(3):409-18. PubMed ID: 48393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]